On Jan 28, 2026, CVSA reported earnings of 2.43 USD per share (EPS) for Q2 26, beating the estimate of 2.23 USD, resulting in a 8.91% surprise. Revenue reached 503.38 million, compared to an expected 498.50 million, with a 0.98% difference.
Looking ahead to Q3 26, -- analysts forecast an EPS of 1.75 USD, with revenue projected to reach 483.52 million USD, implying an decrease of -27.98% EPS, and decrease of -3.95% in Revenue from the last quarter.